Gaudium IVF & Women Health IPO GMP today is Rs 4. Investors can use this GMP along with price band and subscription status for a better IPO review.
Listed
Mainboard IPO
GAUDIUMIVF
Gaudium IVF & Women Health IPO GMP, Subscription & Allotment Status Today
Gaudium IVF & Women Health is a Mainboard IPO with a price band of Rs 75.00 to Rs 79.00 that listed on 27 Feb 2026 at a listing gain of +5.06%. Track its full GMP history, subscription data and listing details here.
- Price Band
- ₹75.00 - ₹79.00
- Lot Size
- 189 Shares
- Bidding Closes
- 24 Feb 2026
- Listing Date
- 27 Feb 2026
Current GMP Status
₹4
+5.06% vs upper band
Est. Listing Gain
+5.06%
Last Trend
27 Feb 2026
Listing Price
₹83.00
Retail Entry
₹14,931
IPO Details
Complete IPO information
| Current GMP | ₹4 |
|---|---|
| Estimated Listing Gain | +5.06% |
| Price Band | ₹75.00 - ₹79.00 |
| Issue Price | Approx ₹79.00 Crores |
| Listing Price | ₹83.00 |
| Lot Size | 189 Shares |
| Issue Type | Mainboard |
| Registrar | TBA |
| Exchange | NSE, BSE |
| Retail Quota | TBA |
| Overall Subscription | TBA |
| Listing Date | 27 Feb 2026 |
| Minimum Investment | ₹14,931 |
Head-to-head
Compare Gaudium IVF & Women Health IPO with similar IPOs
Analysis
IPO Snapshot & Investor Takeaways
At the upper end of its price band, Gaudium IVF & Women Health is priced at ₹79 per share. With a minimum lot size of 189 shares, a retail investor applying for one lot would need approximately ₹14,931 to participate in this Mainboard issue.
The latest recorded Grey Market Premium for Gaudium IVF & Women Health stands at ₹4, implying an estimated listing gain of around 5.06% over the issue price if it holds until listing. This is down ₹4 from its previously recorded level. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.
Mainboard IPOs list on the main platform of BSE/NSE, typically involve larger issue sizes, and draw participation across retail, HNI and institutional (QIB) investor categories.
Timeline
IPO roadmap at a glance
✓
Bidding Opens
20 Feb 2026
✓
Bidding Closes
24 Feb 2026
✓
Allotment
TBA
✓
Listing
27 Feb 2026
Grey Market Premium
Daily GMP status
| Date | GMP | Change | Gain |
|---|---|---|---|
| 27 Feb 2026 | ₹-2.00 | -₹4.00 | -2.53% |
| 25 Feb 2026 | ₹2.00 | -₹3.00 | 2.53% |
| 24 Feb 2026 | ₹5.00 | -₹3.50 | 6.33% |
| 23 Feb 2026 | ₹8.50 | -₹4.00 | 10.76% |
| 18 Feb 2026 | ₹12.50 | - | 15.82% |
Swipe to see more →
Market Lot
Application size breakdown
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 Lot | 189 | ₹14,931 |
| Retail Maximum | 13 Lot | 2,457 | ₹1,94,103 |
| S-HNI Minimum | 14 Lot | 2,646 | ₹2,09,034 |
| S-HNI Maximum | 66 Lot | 12,474 | ₹9,85,446 |
| B-HNI Minimum | 67 Lot | 12,663 | ₹10,00,377 |
Swipe to see more →
Fund Utilization
Objects of the Issue & Official Documents
Analysis
Gaudium IVF IPO – Key Details
| IPO Open Date | February 20, 2026 |
| IPO Close Date | February 24, 2026 |
| Face Value | ₹5 Per Equity Share |
| IPO Price Band | ₹75 to ₹79 Per Share |
| Issue Size | Approx ₹165 Crores |
| Fresh Issue | Approx ₹90 Crores |
| Offer for Sale (OFS) | Approx 94,93,700 Equity Shares |
| Issue Type | Book Build Issue |
| IPO Listing | BSE, NSE |
Analysis
Gaudium IVF IPO – Market Lot Details
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 189 | ₹14,931 |
| Retail Maximum | 13 | 2,457 | ₹1,94,103 |
| S-HNI Minimum | 14 | 2,646 | ₹2,09,034 |
| S-HNI Maximum | 66 | 12,474 | ₹9,85,446 |
| B-HNI Minimum | 67 | 12,663 | ₹10,00,377 |
Analysis
Gaudium IVF IPO – Reservation Details
| Investor Category | Shares Offered | Reservation (%) |
|---|---|---|
| Anchor Investor | – | – |
| QIB (Ex. Anchor) | – | 50% |
| NII | – | 15% |
| Retail | – | 35% |
Analysis
Gaudium IVF IPO – Anchor Investors Details
| Anchor Bidding Date | February 18, 2026 |
| Shares Offered to Anchor Investors | – |
| Anchor Portion Size | – |
| Lock-in Period (50% Shares – 30 Days) | March, 2026 |
| Lock-in Period (50% Shares – 90 Days) | May, 2026 |
Analysis
Gaudium IVF IPO – Important Dates
| IPO Open Date | February 20, 2026 |
| IPO Close Date | February 24, 2026 |
| Basis of Allotment | February 25, 2026 |
| Refunds Initiation | February 26, 2026 |
| Credit to Demat Account | February 26, 2026 |
| IPO Listing Date | February 27, 2026 |
| IPO Bidding Cut-off Time | February 24, 2026 – 5 PM |
Analysis
Gaudium IVF IPO – Promoters & Holding Pattern
| Promoters | Dr. Manika Khanna, Dr. Peeyush Khanna, Vishad Khanna |
| Promoter Holding (Pre Issue) | 6,13,94,384 Shares (99.98%) |
| Promoter Holding (Post Issue) | 7,27,86,884 Shares |
Analysis
Gaudium IVF IPO – Objects of the Issue & Utilisation of Proceeds
| Funding capital expenditure towards establishment of New IVF Centers of the Company | ₹50 Cr |
| Repayment / pre-payment, in full or in part, of certain outstanding loans availed by the Company | ₹20 Cr |
| General Corporate Purpose | – |
Analysis
About Gaudium IVF IPO
Gaudium IVF, founded in March 2015, is one of the leading companies offering In Vitro Fertilization (IVF) treatments for women across India. The company operates its business over 30 locations, with seven hubs (centres) and twenty-eight spokes. The firm treats its patients in various countries, including Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman.
The firm offers various fertility services such as Vitro Fertilisation (IVF), intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and ovulation induction. Its treatments are targeted towards both genders. Moreover, the firm also provides PCOD/PCOS, endometriosis, and special care for women in pregnancy with complex fertility issues. Gaudium IVF also offers treatments targeting male infertility, including advanced sperm retrieval procedures.
Analysis
Gaudium IVF IPO – Company Financial Report
| Period Ended | Revenue (₹ Cr) | Expense (₹ Cr) | PAT (₹ Cr) | Assets (₹ Cr) |
|---|---|---|---|---|
| 2023 | 44.26 | 25.95 | 13.53 | 36.63 |
| 2024 | 48.15 | 31.52 | 10.32 | 51.01 |
| 2025 | 70.96 | 45.54 | 19.13 | 88.51 |
| Sep 2025 | 49.75 | 32.97 | 12.51 | 106.62 |
Analysis
Gaudium IVF IPO – Valuation (FY2025)
| ROE | 41.31% |
| ROCE | 39.70% |
| EBITDA Margin | 40.48% |
| PAT Margin | 26.96% |
| Debt to Equity Ratio | 0.41 |
| Earning Per Share (EPS) | ₹3.12 (Basic) |
| Price / Earning (P/E) Ratio | N/A |
| Return on Net Worth (RoNW) | 41.71% |
| Net Asset Value (NAV) | ₹7.54 |
Analysis
Peer Group Comparison
- There is no listed industry peers available.
Analysis
IPO Lead Managers aka Merchant Bankers
- Sarthi Capital Advisors Pvt. Ltd.
FAQ
Gaudium IVF & Women Health IPO FAQs
Gaudium IVF & Women Health IPO price band is Rs 75.00 to Rs 79.00. Check the latest issue price, lot size and GMP together before applying.
Gaudium IVF & Women Health IPO open date is 20 Feb 2026, close date is 24 Feb 2026, and listing date is 27 Feb 2026.
Gaudium IVF & Women Health IPO lot size is 189 shares. The minimum retail investment is Rs 14,931.
Gaudium IVF & Women Health is classified as a Mainboard IPO. This helps investors quickly understand the issue category and exchange segment.
Gaudium IVF & Women Health IPO subscription status currently shows Subscription data is currently awaited.
Community discussion
Comments
Share a useful question or insight about Gaudium IVF & Women Health.
Leave a comment
Your email address will not be published. All comments and replies are reviewed before appearing.
Keep Exploring
Similar Recent IPOs
Mainboard
Reliance Jio
Price BandTBA
Current GMP₹145
Lot SizeTBA
Mainboard
Vishal Nirmiti
Price Band₹208.00 - ₹220.00
Current GMP₹20 · +9.1%
Lot Size68 Shares
Mainboard
Nityas Gems and Jewellery
Price Band₹70.00 - ₹75.00
Current GMP₹3 · +4.0%
Lot Size200 Shares
Mainboard
Shah Investor's Home
Price Band₹159.00 - ₹167.00
Current GMP₹17 · +10.2%
Lot Size85 Shares
Loading comments...